Covered recipient · General Payments record
STEVEN RICHARD FELDMAN
Allopathic & Osteopathic Physicians Dermatology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2023 · Entire year
$630,467.51
424 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2023 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $438,986.36 | 114 |
| Travel and Lodging | $90,303.56 | 164 |
| Consulting Fee | $86,087.00 | 26 |
| Food and Beverage | $7,437.60 | 112 |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,600.00 | 1 |
| Honoraria | $1,686.00 | 2 |
| Education | $366.99 | 5 |
By paying entity
PY2023 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | $177,778.48 | 126 |
| E.R. Squibb & Sons, L.L.C. | $136,774.69 | 67 |
| Janssen Biotech, Inc. | $118,016.68 | 82 |
| Lilly USA, LLC | $45,078.33 | 24 |
| ABBVIE INC. | $35,168.94 | 31 |
| GENZYME CORPORATION | $18,208.70 | 11 |
| LEO Pharma AS | $13,350.00 | 2 |
| Boehringer Ingelheim International GmbH | $11,266.86 | 15 |
| Janssen Scientific Affairs, LLC | $10,400.00 | 4 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $9,994.18 | 4 |
| LEO Pharma Inc. | $9,963.97 | 6 |
| Amgen Inc. | $8,740.74 | 6 |
| Incyte Corporation | $8,554.69 | 11 |
| Eli Lilly and Company | $8,100.00 | 3 |
| Regeneron Healthcare Solutions, Inc. | $7,542.76 | 18 |
| Samsung Bioepis Co., Ltd. | $4,625.00 | 2 |
| SANOFI-AVENTIS U.S. LLC | $3,896.00 | 1 |
| Organon LLC | $1,686.00 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $581.81 | 3 |
| Vertex Pharmaceuticals Incorporated | $465.00 | 1 |
| Galderma Laboratories, L.P. | $112.63 | 1 |
| Dermavant Sciences, Inc. | $107.17 | 2 |
| UCB, Inc. | $35.96 | 1 |
| PFIZER INC. | $18.92 | 1 |
Page 2 of 9; records 51–100 of 424 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
STEVEN RICHARD FELDMAN
NPI 1720063175 · CMS profile ID 305337
Allopathic & Osteopathic Physicians / Dermatology
WINSTON SALEM, NC
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 9; records 51–100 of 424 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1720063175?year=2023&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- STEVEN RICHARD FELDMAN, NPI 1720063175, CMS profile ID 305337. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 424 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1720063175?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- APA 7
- IndustryPayments. (2026). STEVEN RICHARD FELDMAN, NPI 1720063175, CMS profile ID 305337. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 424 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1720063175?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
- Bluebook
- STEVEN RICHARD FELDMAN, NPI 1720063175, CMS profile ID 305337, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 9; records 51–100 of 424 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1720063175?year=2023&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2023
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30
424 matching records · $630,467.51 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 424.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Inc. | $106.90 | 11/01/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979441 | CMS |
| ABBVIE INC. | $562.00 | 10/31/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 997239739 | CMS |
| ABBVIE INC. | $24.39 | 10/31/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 997239741 | CMS |
| Janssen Biotech, Inc. | $4,050.00 | 10/28/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1061054433 | CMS |
| Sun Pharmaceutical Industries Inc. | $4,565.00 | 10/26/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979345 | CMS |
| Sun Pharmaceutical Industries Inc. | $1,806.42 | 10/26/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979349 | CMS |
| Sun Pharmaceutical Industries Inc. | $125.00 | 10/26/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979353 | CMS |
| Janssen Biotech, Inc. | $403.17 | 10/25/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1061054439 | CMS |
| GENZYME CORPORATION | $49.16 | 10/23/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1049674061 | CMS |
| Janssen Biotech, Inc. | $300.00 | 10/07/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713489 | CMS |
| Janssen Biotech, Inc. | $24.04 | 10/07/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713491 | CMS |
| Boehringer Ingelheim International GmbH | $14.29 | 10/03/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017329463 | CMS |
| Boehringer Ingelheim International GmbH | $478.00 | 10/03/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017329465 | CMS |
| Boehringer Ingelheim International GmbH | $794.43 | 10/03/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017329467 | CMS |
| Boehringer Ingelheim International GmbH | $794.43 | 10/03/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017329469 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.93 | 10/03/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1015667135 | CMS |
| LEO Pharma Inc. | $25.00 | 10/02/2023 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053469639 | CMS |
| Janssen Biotech, Inc. | $187.36 | 09/30/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713527 | CMS |
| Janssen Biotech, Inc. | $15.00 | 09/30/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713529 | CMS |
| LEO Pharma Inc. | $2,670.00 | 09/27/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053469637 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5,208.00 | 09/19/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1015667119 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,257.00 | 09/19/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1015667155 | CMS |
| PFIZER INC. | $18.92 | 09/19/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1049400767 | CMS |
| Sun Pharmaceutical Industries Inc. | $6,225.00 | 09/19/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979357 | CMS |
| Sun Pharmaceutical Industries Inc. | $1,888.16 | 09/19/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979361 | CMS |
| Sun Pharmaceutical Industries Inc. | $120.15 | 09/19/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979365 | CMS |
| Janssen Biotech, Inc. | $6,300.00 | 09/16/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713515 | CMS |
| Janssen Biotech, Inc. | $487.38 | 09/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713517 | CMS |
| Janssen Biotech, Inc. | $255.09 | 09/14/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713521 | CMS |
| Janssen Biotech, Inc. | $100.20 | 09/14/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713523 | CMS |
| Boehringer Ingelheim International GmbH | $2,500.00 | 09/13/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1017329471 | CMS |
| Janssen Scientific Affairs, LLC | $3,900.00 | 09/13/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988761907 | CMS |
| Sun Pharmaceutical Industries Inc. | $6,225.00 | 09/13/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979407 | CMS |
| Sun Pharmaceutical Industries Inc. | $250.00 | 09/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979411 | CMS |
| Sun Pharmaceutical Industries Inc. | $19.00 | 09/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979413 | CMS |
| Sun Pharmaceutical Industries Inc. | $19.00 | 09/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979417 | CMS |
| Sun Pharmaceutical Industries Inc. | $177.87 | 09/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979421 | CMS |
| Sun Pharmaceutical Industries Inc. | $460.30 | 09/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979425 | CMS |
| Sun Pharmaceutical Industries Inc. | $646.88 | 09/13/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979429 | CMS |
| Sun Pharmaceutical Industries Inc. | $121.34 | 09/13/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1053979431 | CMS |
| Janssen Biotech, Inc. | $8,100.00 | 09/11/2023 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713485 | CMS |
| Janssen Biotech, Inc. | $23.57 | 09/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713503 | CMS |
| Janssen Biotech, Inc. | $9.99 | 09/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713507 | CMS |
| Janssen Biotech, Inc. | $35.32 | 09/08/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713509 | CMS |
| Janssen Biotech, Inc. | $177.67 | 09/07/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713495 | CMS |
| Janssen Biotech, Inc. | $422.12 | 09/07/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713497 | CMS |
| Janssen Biotech, Inc. | $447.41 | 09/07/2023 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713501 | CMS |
| Janssen Biotech, Inc. | $85.52 | 09/07/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 988713511 | CMS |
| ABBVIE INC. | $9.23 | 09/06/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 997239737 | CMS |
| Galderma Laboratories, L.P. | $112.63 | 09/06/2023 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1059694503 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $105,755.84 | 8 |
| PY2024 | Principal investigator | $132,244.34 | 33 |
| PY2023 | Recipient | $15,730.00 | 4 |
| PY2023 | Principal investigator | $200,351.35 | 63 |
| PY2022 | Recipient | $4,470.00 | 3 |
| PY2022 | Principal investigator | $121,029.44 | 5 |
| PY2021 | Recipient | $9,235.00 | 5 |
| PY2021 | Principal investigator | $13,391.69 | 3 |
| PY2020 | Recipient | $9,370.00 | 4 |
| PY2020 | Principal investigator | $42,210.08 | 5 |
| PY2019 | Recipient | $34,694.90 | 7 |
| PY2019 | Principal investigator | $242,714.92 | 10 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
8 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Incyte Corporation | $310.00 | 10/22/2025 | Non-covered Recipient Entity WAKE FOREST UNIVERSITY | A Phase 3, Double-Blinded, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis | No dispute reported | 06/30/2026 | 1240615904 |
| Principal investigator 1 | Eli Lilly and Company | $3,000.00 | 05/02/2025 | Non-covered Recipient Entity WAKE FOREST UNIVERSITY HEALTH SCIENCES | PSOSA (PSORIASIS SPECIAL AREAS) - A US-BASED, SINGLE-ARM, PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF NAIL AND SCALP PSORIASIS IMPROVEMENT IN PATIENTS TREATED WITH IXEKIZUMAB | No dispute reported | 06/30/2026 | 1187893698 |
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $76,234.69 | 04/30/2025 | Non-covered Recipient Entity Wake Forest University Health Sciences | Deucravacitinib adherence study | No dispute reported | 06/30/2026 | 1235991887 |
| Principal investigator 1 | LEO Pharma AS | $448.00 | 04/14/2025 | Non-covered Recipient Entity WAKE FOREST UNIVERSITY HEALTH SCIENCES | TRACE STUDY: TRALOKINUMAB REAL WORLD CLINICAL USE: AN OBSERVATIONAL COHORT STUDY OF ATOPIC DERMATITIS PATIENTS PRESCRIBED TRALOKINUMAB | No dispute reported | 06/30/2026 | 1251993082 |
| Principal investigator 1 | E.R. Squibb & Sons, L.L.C. | $20,713.15 | 04/09/2025 | Non-covered Recipient Entity Wake Forest University Health Sciences | A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis | No dispute reported | 06/30/2026 | 1235991889 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $550.00 | 01/22/2025 | Covered Recipient Teaching Hospital NORTH CAROLINA BAPTIST HOSPITAL | A STUDY ABOUT HOW WELL TAK-279 WORKS AND ITS SAFETY IN PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS DURING 60 WEEKS OF TREATMENT WITH A WITHDRAWAL AND RETREATMENT PERIOD | No dispute reported | 06/30/2026 | 1223268334 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $2,000.00 | 01/22/2025 | Covered Recipient Teaching Hospital NORTH CAROLINA BAPTIST HOSPITAL | A STUDY ABOUT HOW WELL TAK-279 WORKS AND ITS SAFETY IN PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS DURING 60 WEEKS OF TREATMENT WITH A WITHDRAWAL AND RETREATMENT PERIOD | No dispute reported | 06/30/2026 | 1223268336 |
| Principal investigator 1 | Takeda Pharmaceuticals U.S.A., Inc. | $2,500.00 | 01/22/2025 | Covered Recipient Teaching Hospital NORTH CAROLINA BAPTIST HOSPITAL | A STUDY ABOUT HOW WELL TAK-279 WORKS AND ITS SAFETY IN PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS DURING 60 WEEKS OF TREATMENT WITH A WITHDRAWAL AND RETREATMENT PERIOD | No dispute reported | 06/30/2026 | 1223268338 |